• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TP53 的表观遗传调控参与前列腺癌的放射抵抗和 DNA 损伤反应信号转导。

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling.

机构信息

Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/ CI-IPOP@ RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy.

出版信息

Signal Transduct Target Ther. 2023 Oct 16;8(1):395. doi: 10.1038/s41392-023-01639-6.

DOI:10.1038/s41392-023-01639-6
PMID:37840069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577134/
Abstract

External beam radiotherapy (RT) is a leading first-line therapy for prostate cancer (PCa), and, in recent years, significant advances have been accomplished. However, RT resistance can arise and result in long-term recurrence or disease progression in the worst-case scenario. Thus, making crucial the discovery of new targets for PCa radiosensitization. Herein, we generated a radioresistant PCa cell line, and found p53 to be highly expressed in radioresistant PCa cells, as well as in PCa patients with recurrent/disease progression submitted to RT. Mechanism dissection revealed that RT could promote p53 expression via epigenetic modulation. Specifically, a decrease of H3K27me3 occupancy at TP53 gene promoter, due to increased KDM6B activity, was observed in radioresistant PCa cells. Furthermore, p53 is essential for efficient DNA damage signaling response and cell recovery upon stress induction by prolonged fractionated irradiation. Remarkably, KDM6B inhibition by GSK-J4 significantly decreased p53 expression, consequently attenuating the radioresistant phenotype of PCa cells and hampering in vivo 3D tumor formation. Overall, this work contributes to improve the understanding of p53 as a mediator of signaling transduction in DNA damage repair, as well as the impact of epigenetic targeting for PCa radiosensitization.

摘要

体外放射治疗 (RT) 是前列腺癌 (PCa) 的主要一线治疗方法,近年来取得了重大进展。然而,RT 抵抗可能会出现,并导致长期复发或疾病恶化。因此,发现新的 PCa 放射增敏靶点至关重要。在此,我们构建了一个放射抵抗的 PCa 细胞系,并发现 p53 在放射抵抗的 PCa 细胞以及接受 RT 的复发/疾病进展的 PCa 患者中高度表达。机制研究表明,RT 可以通过表观遗传调节促进 p53 的表达。具体而言,在放射抵抗的 PCa 细胞中观察到,由于 KDM6B 活性增加,TP53 基因启动子上 H3K27me3 占有率降低。此外,p53 对于有效的 DNA 损伤信号转导和在长时间分割照射诱导的应激下细胞恢复至关重要。值得注意的是,GSK-J4 抑制 KDM6B 显著降低了 p53 的表达,从而削弱了 PCa 细胞的放射抵抗表型,并阻碍了体内 3D 肿瘤的形成。总的来说,这项工作有助于提高对 p53 作为 DNA 损伤修复信号转导中介的理解,以及对表观遗传靶向用于 PCa 放射增敏的影响的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/554324bdf374/41392_2023_1639_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/6804b658a925/41392_2023_1639_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/241cc3ebd41a/41392_2023_1639_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/7be1725c2d4e/41392_2023_1639_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/fef187f65eb5/41392_2023_1639_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/dd010bdf88aa/41392_2023_1639_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/554324bdf374/41392_2023_1639_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/6804b658a925/41392_2023_1639_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/241cc3ebd41a/41392_2023_1639_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/7be1725c2d4e/41392_2023_1639_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/fef187f65eb5/41392_2023_1639_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/dd010bdf88aa/41392_2023_1639_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/10577134/554324bdf374/41392_2023_1639_Fig6_HTML.jpg

相似文献

1
Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling.TP53 的表观遗传调控参与前列腺癌的放射抵抗和 DNA 损伤反应信号转导。
Signal Transduct Target Ther. 2023 Oct 16;8(1):395. doi: 10.1038/s41392-023-01639-6.
2
Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.赖氨酸去甲基化酶 6B 通过控制 c-MYC 表达调控前列腺癌细胞增殖。
Mol Pharmacol. 2022 Feb;101(2):106-119. doi: 10.1124/molpharm.121.000372. Epub 2021 Dec 3.
3
KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.KDM6B 是雄激素调控的基因,通过在前列腺癌细胞中去甲基化 cyclin D1 启动子上的 H3K27me3 发挥致癌作用。
Cell Death Dis. 2021 Jan 6;12(1):2. doi: 10.1038/s41419-020-03354-4.
4
Epigenetic mechanisms underlying prostate cancer radioresistance.前列腺癌放射抵抗的表观遗传机制。
Clin Epigenetics. 2021 Jun 8;13(1):125. doi: 10.1186/s13148-021-01111-8.
5
Profiles of Radioresistance Mechanisms in Prostate Cancer.前列腺癌的放射抗性机制概况
Crit Rev Oncog. 2018;23(1-2):39-67. doi: 10.1615/CritRevOncog.2018025946.
6
Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.浸润性肥大细胞通过调节p38/p53/p21和ATM信号增加前列腺癌对化疗和放疗的抗性。
Oncotarget. 2016 Jan 12;7(2):1341-53. doi: 10.18632/oncotarget.6372.
7
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.MDM2抑制以p53依赖的方式使前列腺癌细胞对雄激素剥夺和放疗敏感。
Neoplasia. 2016 Apr;18(4):213-22. doi: 10.1016/j.neo.2016.01.006.
8
Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG.联合靶向突变型 p53 和 Jumonji 家族组蛋白去甲基化酶增强 H3K27M DIPG 的放疗疗效。
Int J Mol Sci. 2020 Jan 13;21(2):490. doi: 10.3390/ijms21020490.
9
BRCA1 and p53 regulate critical prostate cancer pathways.BRCA1 和 p53 调控关键的前列腺癌通路。
Prostate Cancer Prostatic Dis. 2013 Sep;16(3):233-8. doi: 10.1038/pcan.2013.12. Epub 2013 May 14.
10
RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.对一种抗辐射和辐射敏感的前列腺癌细胞系进行RNA测序分析,突出了DNA修复的相反调控以及放射增敏靶点。
BMC Cancer. 2014 Nov 4;14:808. doi: 10.1186/1471-2407-14-808.

引用本文的文献

1
The Potential Mechanisms of Ochratoxin A in Prostate Cancer Development: An Integrated Study Combining Network Toxicology, Machine Learning, and Molecular Docking.赭曲霉毒素A在前列腺癌发生发展中的潜在机制:一项结合网络毒理学、机器学习和分子对接的综合研究
Toxins (Basel). 2025 Aug 4;17(8):388. doi: 10.3390/toxins17080388.
2
Decoding MUC1 and AR axis in a radiation-induced neuroendocrine prostate cancer cell-subpopulation unveils novel therapeutic targets.解码辐射诱导的神经内分泌前列腺癌细胞亚群中的MUC1和AR轴揭示了新的治疗靶点。
Cell Death Discov. 2025 Jul 3;11(1):306. doi: 10.1038/s41420-025-02597-4.
3
H3K27me3 modulates trained immunity of monocytes in HDM-allergic diseases.

本文引用的文献

1
Radiosensitization of PC3 Prostate Cancer Cells by 5-Thiocyanato-2'-deoxyuridine.5-硫氰基-2'-脱氧尿苷对PC3前列腺癌细胞的放射增敏作用
Cancers (Basel). 2022 Apr 18;14(8):2035. doi: 10.3390/cancers14082035.
2
Relationship between p53 status and the bioeffect of ionizing radiation.p53状态与电离辐射生物效应之间的关系。
Oncol Lett. 2021 Sep;22(3):661. doi: 10.3892/ol.2021.12922. Epub 2021 Jul 14.
3
Genetic and epigenetic bases of prostate tumor cell radioresistance.前列腺肿瘤细胞放射抵抗的遗传和表观遗传基础。
H3K27me3调节HDM过敏性疾病中单核细胞的训练免疫。
Front Immunol. 2025 May 28;16:1572796. doi: 10.3389/fimmu.2025.1572796. eCollection 2025.
4
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study.通过极端表型研究鉴定与转移性前列腺癌相关的罕见种系变异。
medRxiv. 2025 Apr 29:2025.04.28.25326584. doi: 10.1101/2025.04.28.25326584.
5
Discovery of a DNA repair-associated radiosensitivity index for predicting radiotherapy efficacy in breast cancer.发现一种与DNA修复相关的放射敏感性指数用于预测乳腺癌放疗疗效
Front Oncol. 2025 Mar 25;15:1439516. doi: 10.3389/fonc.2025.1439516. eCollection 2025.
6
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways.肿瘤进展中细胞衰老的调控与治疗靶点:机制与途径
Mol Cancer. 2025 Apr 2;24(1):106. doi: 10.1186/s12943-025-02284-z.
7
CHI3L1 mediates radiation resistance in colorectal cancer by inhibiting ferroptosis via the p53/SLC7A11 pathway.几丁质酶3样蛋白1(CHI3L1)通过p53/溶质载体家族7成员11(SLC7A11)途径抑制铁死亡,从而介导结直肠癌的放射抗性。
J Transl Med. 2025 Mar 21;23(1):357. doi: 10.1186/s12967-025-06378-6.
8
Regulation of histone H3K27 methylation in inflammation and cancer.炎症与癌症中组蛋白H3K27甲基化的调控
Mol Biomed. 2025 Mar 5;6(1):14. doi: 10.1186/s43556-025-00254-x.
9
Prostate cancer epigenetics - from pathophysiology to clinical application.前列腺癌表观遗传学——从病理生理学到临床应用
Nat Rev Urol. 2025 Jan 16. doi: 10.1038/s41585-024-00991-8.
10
NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.NSUN6 介导的 NDRG1 mRNA 5-甲基胞嘧啶修饰促进宫颈癌的放射抵抗。
Mol Cancer. 2024 Jul 5;23(1):139. doi: 10.1186/s12943-024-02055-2.
Klin Onkol. 2021 Spring;34(3):220-234. doi: 10.48095/ccko2021220.
4
Epigenetic mechanisms underlying prostate cancer radioresistance.前列腺癌放射抵抗的表观遗传机制。
Clin Epigenetics. 2021 Jun 8;13(1):125. doi: 10.1186/s13148-021-01111-8.
5
TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells.TP53 调节正常和癌细胞放疗分割剂量敏感性。
Sci Rep. 2021 Mar 29;11(1):7119. doi: 10.1038/s41598-021-86681-6.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors.DNA 同源重组基因启动子甲基化可预测睾丸生殖细胞肿瘤对 PARP 抑制剂治疗的反应性。
Mol Oncol. 2021 Apr;15(4):846-865. doi: 10.1002/1878-0261.12909. Epub 2021 Mar 2.
8
JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.JmjC-KDMs KDM3A 和 KDM6B 在低氧条件下调节食管鳞癌细胞的放射抵抗性。
Cell Death Dis. 2020 Dec 14;11(12):1068. doi: 10.1038/s41419-020-03279-y.
9
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.癌症放疗增敏的 DNA 损伤反应信号通路和靶点。
Signal Transduct Target Ther. 2020 May 1;5(1):60. doi: 10.1038/s41392-020-0150-x.
10
Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG.联合靶向突变型 p53 和 Jumonji 家族组蛋白去甲基化酶增强 H3K27M DIPG 的放疗疗效。
Int J Mol Sci. 2020 Jan 13;21(2):490. doi: 10.3390/ijms21020490.